Mitochondrial oxidative stress and metabolic alterations in neurodegenerative disorders

Advances in Cell Aging and Gerontology

Volumn 7, Issue C, 2001, Pages 205-237

  Keller, Jeffrey N ^a   Glazner, Gordon W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35448931550     PISSN: 15663124     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1566-3124(01)07020-1     Document Type: Review

References (216)

1. Ames B.N., Shingenaga M.K., and Hagan T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Nat. Acad. Sci. USA 90 (1993) 7915-7922
2. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J., Staden R., and Young I.G. Sequence and organization of the human mitochondrial genome. Nature 290 (1981) 457-465
3. Ankarcrona M., Dypbukt J.M., Orrenius S., and Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 39 (1996) 321-324
4. Armstrong R.C., Aja T.J., Hoang K.D., Gaur S., Bai X., Alnemri E.S., Litwack G., Karanewsky D.S., and Tomaselli K.J. Activation of the CED/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J. Neurosci. 17 (1997) 553-562
5. 2+ network. J. Cell Biol. 136 (1997) 833-844
6. Bagchi D., Wetscher G.J., Bagchi M., Hinder P.R., Perdikis G., Stohs S.J., Hinder R.A., and Das D.K. Interrelationship between cellular calcium homeostasis and free radical generation in myocardial reperfusion injury. Chem. Biol. Interact. 104 (1997) 65-85
7. Bates T.E., Loesch A., Burnstock G., and Clark J.B. Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation?. Biochem. Biophys. Res. Commun. 218 (1996) 40-44
8. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 19 (1994) 357-366
9. Beal M.F., Ferrante R.J., Henshaw R., Matthews R.T., Chan P.H., Kowall N.W., and Schulz J.B. 3-nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 65 (1995) 919-922
10. Beckman J.S., and Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21 (1993) 330-334
11. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271 (1996) C1424-C1437
12. Behl C., Davis J., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77 (1994) 817-827
13. Belmar E., Garcia-Uglalde G., and Tapia R. Motor alterations and neuronal damage induced by intracerebral administration of Ruthenium red: effect of NMDA receptor antagonist and other anticonvulsant drugs. Mol. Chem. Neuropath. 26 (1995) 285-299
14. Benedetti M.S., and Dostert P. Contribution of amine oxidases to the metabolism of xenobiotics. Drug Metab. Rev. 26 (1994) 355-507
15. Bennett M.C., Diamond D.M., Stryker S.L., Parks J.K., Parker Jr. W.D., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger Schreier P.H., Smith A.J., Staden R., and Young I.G. Cytochrome oxidase inhibition, a novel model of Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 5 (1992) 93-101
16. Bennett M.C., Mlady G.W., Fleshner M., and Rose G.M. Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity. Proc. Natl. Acad. Sci. 93 (1996) 1330-1334
17. Benzi G., and Moretti A. Are reactive oxygen species involved in Alzheimer's disease?. Neurobiol. 16 (1995) 661-674
18. Bernardi P. The permeability transition pore. Control points of a cyclosporin A- sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta 1275 (1996) 5-9
19. Bernardi P., Broekemeir K.M., and Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore, a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr. 26 (1994) 509-517
20. Bernardi P., Colonna R., Constantini P., Eriksson O., Fontaine E., Ichas F., Massari S., Nicolli A., Petronilli V., and Scorrano L. The mitochondrial permeability transition. Biofactors 8 (1998) 273-281
21. Blass J.P. Metabolic alterations common to neural and non-neural cells in Alzheimer's disease. Hippocampus 3 (1993) 45-53
22. Bolanos V.P., Almedia A., Stewart V., Peuchen S., Land J.M., Clark J.B., and Heales S.J.R. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68 (1997) 227-240
23. Bossy-Wetzel E., Newmeyer D.D., and Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17 (1998) 37-49
24. Boveris A., Cadenas E., and Stoppani A.O.M. Role of Ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem. J. 156 (1976) 435-444
25. Boveris A., and Chance B. The mitochondrial generation of hydrogen peroxide. Biochem. J. 134 (1984) 707-716
26. Bredesen D.E. Neural apoptosis. Ann. Neurol. 38 (1995) 839-851
27. Brancolini C., and Schneider C. Cut and die: proteolytic cascades regulating apoptosis. Adv. Clin. Path. 1 (1997) 177-189
28. Brand M.D., Chien L.F., Ainscow L.F., Rolfe D.F., and Porter R.K. The causes and functions of mitochondrial proton leak. Biochim. Biophys. Acta. 1187 (1994) 132-139
29. 2+ and oxidative stress. FEBS Lett. 304 (1992) 192-194
30. Brown G.K., and Squier M.V. Neuropathology and pathogenesis of mitochondrial diseases. J. Inherit Metab. Dis. 19 (1996) 553-572
31. Brown M.D., Voljavec A.S., Lott M.T., MacDonald I., and Wallace D.C. Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases. FASEB J. 6 (1992) 2791-2799
32. Carafoli E. Intracellular calcium homeostasis. Ann. Rev. Biochem. 56 (1987) 395-433
33. Castilho R.F., Kowaltowski A.J., and Vercesi A.E. 3,5,3′-triiodothyronine induces mitochondrial permeability transition mediated by reactive oxygen species and membrane protein thiol oxidation. Arch. Biochem. Biophys. 354 (1998) 151-157
34. Chan P.H., Epstein C.J., Li Y., Huang T.T., Carlson E., Kinouchi H., Yang G., Kamii H., Mikawa S., and Kondo T. Transgenic mice and knockout mutants in the study of oxidative stress in brain injury. J. Neurotrauma 12 (1995) 815-824
35. Chan P.H., Epstein C.J., Li Y., Huang T.T., Carlson E., Mikawa S., Kondo T., Chen S.F., and Reola L. Studies of neuronal injury mechanism in focal stroke using mitochondrial manganese superoxide dismutase-deficient mice. In: Kriegelstein J. (Ed). Pharmacolgy of Cerebral Ischemia (1996), Medpharm, Stuttgart 573-579
36. Chandrasekaran K., Stoll J., Giordano T., Atack J.R., Matocha M.F., Brady D.R., and Rapoport S.I. Differential expression of cytochrome oxidase. (COX). genes in different regions of monkey brain. J. Neurosci. Res. 32 (1992) 415-423
37. Chernyak B.V., and Bernardi P. The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur. J. Biochem. 238 (1996) 623-630
38. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
39. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6 (1996) 667-672
40. Chomyn A., Martinuzzi A., Yoneda M., Daga A., Hurko O., Johns D., Lai S.T., Nonaka I., Angelini C., and Attardi G. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc. Natl. Acad. Sci. USA 89 (1992) 4221-4225
41. Clements A., Walsh D.M., Williams C.H., and Allsop D. Effects of the mutation Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amaloid β/A4 peptide. Neurosci. Lett. 161 (1993) 17-20
42. Cotman C.W., and Su J.H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6 (1996) 493-506
43. Coyle J.T., and Puttfarken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262 (1993) 689-695
44. Cross A.R., and Jones O.T.G. Enzymatic mechanisms of superoxide generation. Biochem. Biophys. Acta. 1057 (1991) 281-298
45. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., and Parker Jr. W.D. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 94 (1997) 4526-4531
46. D'Mello S.R. Molecular regulation of neuronal apoptosis. Curr. Top. Dev. Biol. 39 (1998) 187-213
47. de Vries D.D., van Engelen B.G., Gabreelsm F.J., Ruitenbeek W., and van Oost B. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann. Neurol. 34 (1993) 410-422
48. Dugan L.L., Sensi S.L., Canzoniero L.M., Handran S.D., Rothman S.M., Goldberg M.P., and Choi D.W. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15 (1995) 6377-6388
49. Dyrks T., Dyrks E., Hartmann T., Masters C., and Beyreuther K. Amyloidogenicity of β A4 and β A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267 (1992) 18210-18217
50. Dyrks T., Dyrks E., Masters C.L., and Beyreuther K. Amyloidogenicity of rodent and human β A4 sequences. FEBS Lett. 324 (1993) 231-236
51. Esposito L.A., Melov S., Panov A., Cottrell B.A., and Wllace D.C. Mitochonrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 96 (1999) 4820-4825
52. Esterbauer H. Cytotoxicity and genotoxicity of lipid peroxidation products. Am. J. Clin. Nutr. 57 (1993) 779S-786S
53. Esterbauer H., Schauer R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11 (1991) 81-128
54. France-Lanord V., Brugg B., Michel P.P., and Ruberg M. Mitochondrial free radical signal in ceramide dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J. Neurochem. 69 (1997) 1612-1621
55. Gardner-Medwin D., Dale G., and Parkin J.M. Lactic acidosis with mitochondiral myopathy and recurrent coma (Abstr). First International Congress of Child Neurology No 47 (1975)
56. Ghagfourifar P., and Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 418 (1997) 291-296
57. Glazner G.W. Mitochondrial mutations and neurodegenerative disease. Genetic Aberrancies and Neurodegenerative Disorders. In: Mattson M.P. (Ed). Advances in Gerontology (1999), JAI Press, Stamford CT In press
58. Goldman R., Moshonov S., and Zor U. Generation of reactive oxygen species in a human keratinocyte cell line: role of calcium. Arch. Biochem. Biophys. 350 (1998) 10-18
59. Gonzalezuleta M., Enez L.M., Mukhina G., Lebovitz R.M., Zwacka Z.M., Engelhardt J.F., Oberley L.W., Dawson V.L., and Dawson T. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18 (1998) 2040-2055
60. Goto Y., Nonaka I., and Horai S. A mutation in the tRNALeucine (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1981) 651-653
61. Gotz M.E., Kunig G., Riederer P., and Youdim M.B.H. Oxidative stress: Free radical production in neural degeneration. Pharmac. Ther. 63 (1994) 37-122
62. Graeber M.B., and Muller U. Recent developments in the molecular genetics of mitochondrial disorders. J. Neurol. Sci. 153 (1998) 251-263
63. Greenlund L.J., Deckworth T.L., and Johnson E.M. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed cell death. Neuron 14 (1995) 303-315
64. Gunter T.E., and Pfeiffer D.R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol 258 (1990) C755-C786
65. Gunter T.E., Gunter K.K., Sheu S.S., and Gavin C.E. Mitochondrial calcium transport: physiological and pathological relevence. Am. J. Physiol. 267 (1994) C313-C339
66. 2+ transients. Biochim. Biophys. Acta 1366 (1998) 5-15
67. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17 (1997) 4212-4222
68. Hajnoczky G., Robb-Gaspers L.D., Seitz M.B., and Thomas A.P. Decoding of cytosolic calcium oscillations in the mitochondria. Cell 82 (1995) 415-424
69. Halliwell B., and Gutteridge J.M.C. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 246 (1986) 501-514
70. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20 (1997) 154-159
71. Henderson C.E. Programmed cell death in the developing nervous system. Neuron 17 (1996) 579-585
72. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., and Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide, relevance to Alzheimer disease. Proc. Natl. Acad. Sci. 91 (1994) 3270-3274
73. Hirsch T., Susin S.A., Marzo I., Marchetti P., Zamzami N., and Kroemer G. Mitochondrial permeability transition in apoptosis and necrosis. Cell. Biol. Toxicol. 14 (1998) 141-145
74. Hockenberry D.M., Oltvai Z.N., Xiao-Ming Y., Milliman C.L., and Korsemeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1994) 241-251
75. Hoek J.B., Farber J.L., Thomas A.P., and Wang X. Calcium ion-dependent signaling and mitochondrial dysfunction: mitochondrial calcium uptake during hormonal stimulation in intact liver cells and its implication for the mitochondrial permeability transition. Biochem. Biophys. Acta. 1271 (1995) 93-102
76. Hoek J.B., Rode E.W., and Wang X. Hormonal stimulation, mitochondrial calcium accumulation, and the control of the mitochondrial permeability transition in intact hepatocytes. Mol. Cell. BioL. Chem. 174 (1997) 173-179
77. Holt I.J., Harding A.E., Petty R.K., and Morgan-Hughes. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46 (1990) 428-433
78. Hofmann K. The modular nature of apoptotic signaling proteins. Cell. Mol. Life Sci. 55 (1999) 1113-1128
79. Humphries K.M., Yoo Y., and Szweda L.I. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 37 (1998) 552-557
80. Ichas F., Jouaville L.S., Sidash S.S., Mazat J.P., and Holmuhamedov E.L. Mitochondrial calcium spiking: a transduction mechanism based on calcium-induced permeability transition involved in cell calcium signalling. FEBS Lett. 348 (1994) 211-215
81. James A.M., Wei Y.H., Pang C.Y., and Murphy M.P. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem. J. 318 (1996) 401-407
82. Jacob R.A., and Burri B.J. Oxidative damage and defense. Am. J. Clin. Nutr. 63 (1996) 985S-990S
83. Janetzky B., Hauck S., Youdim M.B., Riederer P., Jellinger K., Pantucek F., Zochling R., Boissl K.W., and Reichmann H. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 169 (1994) 126-128
84. Jesberger J.A., and Richardson J.S. Oxygen free radicals and brain dysfunction. Int. J. Neurosci. 57 (1991) 1-17
85. Jimenez-Jimenez F.J., Garcia-Ruiz P.J., and Bustos F. Calcium, neuronal death, and neurological disease. Rev. Neurol. 24 (1996) 1199-1209
86. Jun A.S., Trounce I.A., Brown M.D., Shoffner J.M., and Wallace D.C. Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol. Cell. Biol. 16 (1996) 771-777
87. Kadenbach B., Schneyder B., Mell O., Stroh S., and Reimann A. Respiratory chain proteins. Rev. Neurol. 147 (1991) 436-442
88. Kantrow S.P., and Piantadosi C.A. Release of cytochrome c from liver mitochondria during permeability transition. Biochem. Biophys. Res. Comm. 232 (1997) 669-671
89. Kearns N.P., and Sayre G.P. Retinitis pigmentosa, external ophthalmoplegia, and complete heart block. Arch. Ophthalmol. 60 (1958) 280-289
90. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., and Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid b-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 68 (1997) 273-284
91. Keller J.N., Kindy M.S., Holtsberg F.W., St. Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Hutchins J.B., and Mattson M.P. Mn-SOD prevents neural apoptosis by suppression of peroxynitrite production and consequent lipid peroxidation and mitochondrial dysfunction, and reduces ischemic brain injury in vivo. J. Neurosci. 18 (1998) 687-697
92. Keller J.N., Guo Q., Holtsberg F.W., and Mattson M.P. Expression of the L286V presenilin-1 mutation confers increased susceptibility to mitochondrial toxin-induced apoptosis. J. Neurosci. 18 (1998) 6997-7003
93. King M., Koga Y., Davidson M., and Schon E. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeucine (UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol. Cell. Biol. 12 (1992) 180-190
94. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., and Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59 (1992) 776-779
95. Kluck R.M., Bossy-Wetzel E., Green D.R., and Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275 (1997) 1132-1136
96. Knudson C.M., Tung K.S., Tourtelle W.G., Brown G.A., and Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270 (1995) 96-99
97. Kristal B.S., and Dubinsky J.M. Mitochondrial permeability transition in the central nervous system: induction by calcium cycling dependent and independent pathways. J. Neurochem. 69 (1997) 524-538
98. Kristal B.S., Park B.K., and Yu B.P. 4-hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271 (1996) 6033-6038
99. Kroemer G., Zamzami N., and Susin S.A. Mitochondrial control of apoptosis. Immunol. Today 18 (1997) 44-51
100. Kruman I.I., and Mattson M.P. Pivotal role of mitochondrial calcium uptake in neuronal cell apoptosis and necrosis. J. Neurochem. 72 (1999) 529-540
101. Kruman I., Bruce A.J., Bredesen D.E., Waeg G., and Mattson M.P. Evidence that 4 hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17 (1997) 5089-5100
102. Kruman I., Guo Q., and Mattson M.P. Calcium and reactive oxygen species mediate staurosporine induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51 (1998) 293-308
103. Kunkel T.A., and Loeb L.A. On the fidelity of DNA replication. Effect of divalent metal ion activators and deoxyribonucleoside triphosphate pools on in vitro mutagenesis. J. Biol. Chem. 254 (1979) 5718-5725
104. Kunkel T.A., and Loeb L.A. Fidelity of mammalian DNA polymerases. Science 213 (1981) 765-767
105. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
106. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11 (1997) 118-124
107. Leber T. Ueber hereditare und congenital angelegte Sehnopsinlieden. Albrecht v. Graefes Arch. Ophthalmol. 17 (1871) 249-291
108. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., and Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366 (1998) 177-196
109. Lenaz G. Role of mitochondria in oxidative stress and aging. Biochim. Biophys. Acta 11366 (1998) 53-67
110. 2-released fatty acids is an early Event in tumour necrosis factor alpha-treated WEHI-164 cells. Biochem. Biophys. Res. Comm. 221 (1996) 531-538
111. Levy E., Carman M.D., Fernandez-Madrid I., Lieberburg I., Power M.D., vanDuinen S.G., Bots G.T., Luyendijk W., and Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248 (1990) 1124-1126
112. Li J.J., and Oberley L.W. Overexpression of manganese containing superoxide dismutase confers resistance to the cytotoxicity of tumour necrosis factor α and/or hypothermia. Cancer Res. 57 (1997) 1001-1008
113. + currents at mouse motor nerve terminals. Neuropharmacology 35 (1996) 615-626
114. Liu X., Kim N.C., Yang J., Jemmerson R., and Wanf X. Induction of apoptotic program in cell free extract: requirement for dATP and cytochrome C. Cell 86 (1996) 147-157
115. 2 by superoxide. Arch. Biochem. Biophys. 15 (1997) 187-192
116. Mah S.P., Zhong L.T., Liu Y., Roghani A., Edwards R.H., and Bredesen D.E. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60 (1993) 1183-1186
117. Malis C.D., and Bonventre J.V. Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria. J. Biol. Chem. 261 (1986) 14201-14208
118. Marchetti P., Susin S.A., Decaudin D., Gamen S., Castedo M., Hirsch T., Zamzami N., Naval J., Senik A., and Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184 (1996) 115-125
119. Marchetti P., Hirsch T., Zamzami N., Castedo M., Decaudin D., Susin S.A., Masse B., and Kroemer G. Mitochondrial permeability transition triggers Lymphocyte apoptosis. J. Immunol. 157 (1996) 4830-4836
120. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Rad. Biol. Med. 23 (1997) 134-147
121. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowsky H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., and Huarte J. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13 (1994) 1017-1030
122. Mattson M.P. Cellular actions of β-amyloid precursor protein and its soluble and Fibrillogenic derivatives. Physiol. Rev. 77 (1997) 1081-1132
123. Mattson M.P., and Scheff S.W. Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma 11 (1994) 3-33
124. Mattson M.P., and Mark R.J. Excitotoxicity and excitoprotection in vitro. Adv. Neurol. 71 (1996) 1-30
125. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16 (1993) 409-414
126. Mattson M.P., Barger S.W., Begley J.G., and Mark R.J. Calcium, free radicals and excitotoxic neuronal death in primary cell culture. Meth. Cell Biol. 46 (1995) 187-216
127. Mattson M.P., Furukawa K., Bruce A.J., Mark R.J., and Blanc E.M. Calcium Homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. Molecular Mechanisms of Dementia. Humana Press (1996) 103-143
128. Mattson M.P., Guo Q., Furukawa K., and Pedersen W.A. Presenilins, the Endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70 (1998) 1-14
129. McConley D.J., and Orrenius S. The role of calcium in the regulation of apoptosis. J. Leukoc. Biol. 59 (1995) 775-783
130. McConkey D.J., and Orrenius S. Signal transduction pathways in apoptosis. Stem Cells 14 (1996) 619-631
131. McCormack J.G., Halestrap A.P., and Denton R.M. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 70 (1990) 391-425
132. McDonald J.W., and Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15 (1990) 41-70
133. 3]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Biochem. Pharmacol. 52 (1996) 29-34
134. Merry D.E., and Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu. Rev. Neurosci. 20 (1997) 245-267
135. Miller S.W., Trimmer P.A., Parker Jr. W.D., and Davis R.E. Creation and characterization of mitochondrial DNA-depleted cell lines with "neuronal-like" properties. J. Neurochem. 67 (1996) 1897-1907
136. 2+ concentration in living single rat cardiac myocytes. Am. J. Physiol. 261 (1991) H1123-H1134
137. Montine K.S., Olson S.J., Amarnath V., Whetsell W.O., Graham D.G., and Montine T.J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's diseases associated with inheritance of ApoE4. Am. J. Pathol. 150 (1997) 437-443
138. Moudy A.M., Handran S.D., Goldberg M.P., Ruffin N., Karl I., and Kranz-Eble P. Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy. Proc. Natl. Acad. Sci. USA 92 (1995) 729-733
139. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., and Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal brain ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18 (1998) 205-213
140. 2+ regulates phosphorylating respiration by normal rat liver and AS-30D hepatoma mitochondria by different mechanisms. J. Biol. Chem. 265 (1990) 10527-10534
141. Mutisya E.M., Bowling A.C., and Beal M.F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63 (1994) 2179-2184
142. Nakamura M., Nakano S., Goto Y., Ozawa M., Nagahama Y., Fukuyama H., Akiguchi I., Kaji R., and Kimura J. A novel point mutation in the mitochondrial tRNAser(UCN) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem. Biophys. Res. Commun. 214 (1995) 86-93
143. Newman N.J. Neuro-ophthalmology, the afferent visual system. Curr. Opin Neurol. (1993) 738-746
144. Newmeyer D.D., Farschon D.M., and Reed J.C. Cell free apoptosis in Xeonopus extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79 (1994) 353-364
145. Nicholls D.G. A role for mitochondria in the protection of cells against calcium overload?. Prog. Brain Res. 63 (1985) 97-106
146. Nicotera P., Bellomo G., and Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Toxicol. 32 (1992) 449-470
147. Nicotera P., Ankarcrona M., Bonfoco E., Orrenius S., and Lipton S.A. Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neuro. 72 (1997) 95-101
148. Olney J.W., and de Gubareff T. Glutamate neurotoxicity and Huntington's chorea. Nature 271 (1978) 557-559
149. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
150. Otabe S., Sakura H., Shimokawa K., Mori Y., Kadowaki H., Yasuda K., Nonaka K., Hagura R., Akanuma Y., and Yazaki Y. The high prevalence of the diabetic patients with a mutation in the mitochondrial gene in Japan. J. Clin. Endocrinol. Metab. 79 (1994) 768-771
151. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14 (1991) 453-501
152. Ortiz R.G., Newman N.J., Shoffner J.M., Kaufman A.E., Koontz D.A., and Wallace D.C. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch. Ophthalmol. 111 (1993) 1525-1530
153. Packer M.A., and Murphy M.P. Peroxynitrite formed, by simultaneuos nitric oxide and superoxide generation causes cyclosporin-A sensitive mitochondrial calcium efflux and depolarization. Eur. J. Biochem. 234 (1995) 231-239
154. Parker Jr. W.D. Cytochrome oxidase deficiency in Alzheimer's disease. Ann. N.Y. Acad. Sci. 640 (1991) 59-64
155. Parker Jr. W.D., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A., and Cullum C.M. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44 6 (1994) 1086-1090
156. Partridge R.S., Monroe S.M., Parks J.K., Johnson K., Parker Jr. W.D., Eaton G.R., and Eaton S.S. Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particles. Arch. Biochem. Biophys. 310 (1994) 210-217
157. Pastorino J.G., Snyder J.W., Serroni A., Hoek J.B., and Farber J.L. Cyclosporin A and carnitine prevent anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J. Biol. Chem. 268 (1993) 13791-13798
158. 2+. J. Biol. Chem. 268 (1993) 1011-1016
159. Petronilli V., Nicolli A., Costantini P., Colonna R., and Bernardi P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim. Biophys. Acta 1187 (1994) 255-259
160. Pettman B., and Henderson C.E. Neuronal cell death. Neuron 20 (1998) 633-647
161. Picklo M.J., Amarnath V., McIntyre J.O., Graham D.G., and Montine T.J. 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J. Neurochem. 72 (1999) 1617-1624
162. Pralang W.F., Hunyady L., Varnai P., Wollhiem C.B., and Spat A. Pyridine nucleotide redox state parallels production of aldosterone in potassium-stimulated adrenal glomerulosa cells. Proc. Nat. Acad. Sci. USA 89 (1992) 132-136
163. 2+ accumulation in sympathetic neurons: spatial and temporal characteristics. J. Neurosci. 19 (1999) 6372-6384
164. 2+ transients. J. Biol. Chem. 269 (1994) 27310-27314
165. Quillet-Mary A., Jaffrezout J.P., Mansat V., Bordier C., Naval J., and Lauren G. Implications of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J. Biol. Chem. 272 (1997) 21388-21395
166. Rasmussen H. Modulation of cell function in the calcium messenger system. Rev. Physiol. Biochem. Pharmacol. 95 (1983) 111-148
167. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature 387 (1997) 773-776
168. Richter C. Prooxidants and mitochondrial calcium, their relationship to apoptosis and oncogenesis. FEBS Lett. 325 (1993) 104-107
169. Richter C., and Cass G.E.N. Oxidative stress in mitochondria: its relationship to cellular calcium homeostasis, cell death, proliferation, and differentiation. Chem. Biol. Interact. 77 (1991) 1-23
170. Richter C., and Schlegel J.Z. Mitochondrial calcium release induced by prooxidants. Toxicol. Lett. 67 (1993) 119-127
171. Richter C., Park J.W., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA 85 (1988) 6465-6467
172. Riederer P., Konradi C., Hebenstreit G., and Youdim M.B. Neurochemical perspectives to the function of monoamine oxidase. Acta. Neurol. Scand. Suppl. 126 (1989) 41-45
173. Rothman S.M. Glutamate and anoxic neuronal death in vitro. Adv. Exp. Med. Biol. 203 (1986) 687-695
174. Ruck A., Dolder M., Wallimann T., and Brdiczka D. Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Lett. 426 (1998) 97-101
175. Satoh T., Ross C.A., Villa A., Supattapone S., Pozzan T., Snyder S.H., and Meldolesi J. The inositol 1, 4, 5-triphosphate receptor in cerebellar Purkinje cells: quantitative immunogold labeling reveals concentration in an ER subcompartment. J. Cell Biol. 111 (1991) 615-624
176. Schapira A.H., Cooper J.M., Dexter D., Jenner P., Clark J.B., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's. Lancet 1 (1989) 1269
177. Shearman M.S., Ragan C.I., and Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of b-amaloid-mediated cell death. Proc. Nat.l Acad. Sci. USA 91 (1994) 1470-1474
178. Schrieber S.L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 253 (1991) 283-287
179. Schrieber S.L. Immunophilin sensitive protein phosphatase action in cell signaling pathways. Cell 70 (1992) 365-368
180. Schwartz L.M., and Milligan C.E. Cold thoughts of death: the role of ICE proteases in neuronal cell death. Trends Neurosci. 10 (1996) 555-563
181. Sheehan J.P., Swerdlow R.H., Miller S.W., Davis R.E., Parks J.K., Parker W.D., and Tuttle J.B. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J. Neurosci. 17 (1997) 4612-4622
182. Shoffner J.M. Mitochondrial defects in basal ganglia diseases. Curr. Opin. Neurol. 8 (1995) 474-479
183. Shoffner J.M., Lott M.T., Lezza A.M.S., Seibel P., Ballinger S.W., and Wallace D.C. Myoclonic epilepsy and tagged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA (Lys) mutation. Cell 61 (1990) 931-937
184. Shoffner J.M., Lott M.T., and Wallace D.C. MERRF: a model disease for understanding the principles of mitochondrial genetics. Rev. Neurol. 147 (1991) 431-435
185. Shoji Y., Uedono Y., Ishikura H., Takeyama N., and Tanaka T. DNA damage induced by tumor necrosis factor alpha in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology 84 (1995) 543-548
186. Sies H. Biochemistry of oxidative stress 25 (1986), Agnew Chem. Int. England 1058-1071
187. Siesjo B.K., Agardh C.D., and Bengtsson F. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1 (1989) 165-211
188. 2+ regulation in neuronal and glial cell signaling. Brain Res. Rev. 26 (1998) 72-81
189. Singer T.P., Ramsay R.R., and Ackrell B.A. Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies. Biochim. Biophys. Acta. 1271 (1995) 211-219
190. Skulachev V.P. Why are mitochondria involved in apoptosis. FEBS Lett. 397 (1996) 7-10
191. Slater A.F., Stefan C., Nobel I., van deb Dobbelsteen D.J., and Orrenius S. Signaling mechanisms and oxidative stress in apoptosis. Toxicol. Lett. 82-83 (1995) 149-153
192. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marcheti P., Macho A., Daugas E., Geukens M., and Kroemer G. Bcl-2 inhibits the release of an apoptogenic protease. J. Exp. Med. 184 (1996) 1331-1341
193. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., Bennett J.P., Davis R.E., and Parker Jr. W.D. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40 (1996) 663-671
194. 2+ ATP-ase, and calsequestrin. J. Neurosci. 12 (1992) 489-505
195. 2+) dependent inner membrane permeability transition. Biochem. J. 294 (1993) 719-725
196. Tan S., Sagara Y., Liu Y., Maher P., and Schubert D.T. The regulation of reactive oxygen species production during programmed cell death. J. Cell. Biol. 141 (1998) 1423-1432
197. Tatuch Y., Christodoulou J., Feigenbaum A., Clarke J.T., Wherret J., Smith C., Rudd N., Petrova-Benedict R., and Robinson B.H. Heteroplasmic mtDNA mutation. (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am. J. Hum. Genet. 50 (1992) 852-858
198. Taylor R.W., Chinnery P.F., Haldane F., Morris A.A., Bindoff L.A., Wilson J., and Turnbull D.M. MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA. Ann. Neurol. 40 (1996) 459-462
199. Tenneti L., D'Emilia D.M., Troy C.M., and Lipton S.A. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 71 (1998) 946-959
200. Thomas E., and Reed D.J. Effects of extracellular calcium omission on isolated hepatocytes: loss of mitochondria membrane potential and protection by inhibitors of uniport calcium transduction. J. Pharmacol. Exp. Ther. 245 (1988) 501-507
201. Troy C.M., Stefanis L., Greene L.A., and Shelanski M.L. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells. J. Neurosci. 17 (1997) 1911-1918
202. Turrens J.F., and Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191 (1980) 421-427
203. Tzagoloff A. Mitochondria (1982), Plenum Press, New York
204. Van de Water B., Zoeteweiji J.P., Bont H.J.G.M., Mulder G.J., and Nagelkerke J.F. Role of mitochondrial calcium in the oxidative stress induced dissipation of the mitochondrial membrane potential. J. Biol. Chem. 269 (1994) 14546-14552
205. Wadia J.S., Chalmers-Redman R.M.E., Ju W.J., Carlile G.W., Phillips J.L., Fraser A.D., and Tatton W.G. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: timecourse and modifications by (-)-Deprenyl. J. Neurosci. 18 (1998) 932-947
206. Wallace D.C. Mitochondrial DNA sequence variation in human evolution and disease. Proc. Natl. Acad. Sci. USA 91 (1994) 8739-8746
207. Waring P., and Beaver J. Cyclosporin A rescues thymocytes from apoptosis induced by very low concentrations of thapsigargin: effects on mitochondrial function. Exp. Cell Res. 227 (1996) 264-276
208. Wei Y.H. Oxidative stress and mitochondrial DNA mutations in human aging. Proc. Soc. Exp. Biol. Med. 217 (1998) 53-63
209. Wisniewski T., Ghiso J., and Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Comm. 179 (1991) 1247-1254
210. Wisniewski T., Ghiso J., and Frangione B. Biology of Aβ amyloid in Alzheimer's disease. Neurobiol. Dis. 4 (1997) 313-328
211. Wong G.H., Elwell J.H., Oberley L.W., and Goeddel D.V. Manganese superoxide dismutase is essential for cellular resistance to tumor necrosis factor. Cell 58 (1989) 923-931
212. Woods N.M., Cuthbertson K.S.R., and Cobbold P.H. Repetitive transient rises in cytoplasmic free calcium in hormone stimulated hepatocytes. Nature 319 (1986) 600-602
213. Yuan J. Transducing signals of life and death. Curr. Opin. Cell. Biol. 9 (1997) 247-251
214. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J.L., Petit P.X., and Kroemer G. Reduction of the mitochondrial membrane potential constitutes an early reversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181 (1995) 1661-1672
215. Zamzami N., Marchetti P., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Zamzami N., Marchetti P., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., and Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed. cell death. J. Exp. Med. 182 (1995) 367-377
216. Zorati M., and Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta. 1241 (1995) 139-176